Latest News & Features
Americas
State law cannot force drug makers to participate in the ‘patent dance’ provided for by the Biologics Price Competition and Innovation Act. 15 December 2017
Big Pharma
While the impact of the European Medicines Agency’s relocation from London to Amsterdam is unknown, industry and government will try to ensure that the UK remains at the forefront of medicines regulation, says Rachel Bradley of Penningtons Manches. 15 December 2017
Big Pharma
France-headquartered Sanofi presented key updates to its research and development strategy yesterday, outlining three key shifts. 15 December 2017
Americas
US-based Vertex Pharmaceuticals and CRISPR Therapeutics have revealed plans to jointly develop and commercialise an investigational gene-editing treatment. 14 December 2017
Big Pharma
The EU General Court has dismissed an appeal from a Spanish laboratory which had sought to have part of a European Union Intellectual Property Office trademark decision annulled. 14 December 2017
Americas
Allergan has boosted its focus on women’s health with the acquisition of Repros Therapeutics, a development stage biopharmaceutical company. 13 December 2017
Americas
Forest Laboratories, a subsidiary of Allergan, has failed in its attempt to overturn a district court ruling in its patent battle with Teva. 13 December 2017
Big Pharma
Teva has dropped its litigation over two US patents against Mylan, after a district court adopted Mylan’s interpretation of the patents. 12 December 2017
Americas
Gilead Sciences has built on its acquisition of cell therapy company Kite Pharma with another purchase. 12 December 2017
Big Pharma
The UK government has announced a deal between the life sciences sector and the government, aimed at ensuring that the “next wave of breakthrough treatments” and innovative medical research and technologies are created in the country. 11 December 2017